Director
Seoyoung C Kim, M.D., Sc.D.
Seoyoung C. Kim, M.D, Sc.D., M.S.C.E, is an Associate Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. She is board-certified in Rheumatology, and co-appointed in the Division of Rheumatology, Immunology and Allergy at Brigham and Women’s Hospital. Her research focuses on comparative safety and effectiveness of medications for the rheumatic diseases as well as health services/outcome research in Rheumatology.
Dr. Kim graduated from the College of Medicine at Hanyang Universtiy in Seoul, Korea and completed residency training in Internal Medicine at State University of New York at Buffalo. Her fellowship training in Rheumatology was completed at the University of Pennsylvania and Brigham and Women’s Hospital. She received a master’s degree in Clinical Epidemiology at the University of Pennsylvania in 2009. She finished a doctoral degree in Epidemiology at Harvard School of Public Health, focusing on pharmacoepidemiology of drugs used in Rheumatology. Link to Harvard Catalyst |
Faculty Members
Rishi J Desai M.S., Ph.D.
Rishi J Desai, MS, PhD, is an Assistant Professor of Medicine at Harvard Medical School and an Associate Epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. His research focuses on generating high-quality evidence for comparative safety and effectiveness of drug treatments for chronic diseases, especially in patient populations typically underrepresented in clinical trials, including pregnant women, the elderly, and patients with multiple chronic conditions. His research projects have mainly concentrated on rheumatology and cardiology; where he has extensively used observational study designs as well as systematic reviews to answer clinically important research questions related to drug effects on a variety of health outcomes. He also has a special interest in applied methodological research aimed at improving confounding control in observational studies.
Link to Havard Catalyst |
Daniel H. Solomon M.D., M.P.H.
Daniel Solomon, MD, MPH, is a Professor of Medicine at Harvard Medical School and Chief of the Section of Clinical Sciences in Rheumatology and is co-appointed in the Division of Pharmacoepidemiology and Pharmacoeconomics. The focus of his research is health services research, quality of care, and pharmacoepidemiology as it pertains to rheumatic diseases and osteoporosis. Specific topics of interest include: indicators of quality prescribing, patterns of medication use for osteoporosis, quality improvement in osteoporosis care, and cardiovascular disease in patients with rheumatoid arthritis. Dr. Solomon is Chair of the Quality of Care Committee of the American College of Rheumatology and was awarded the Henry Kunkel Young Investigator Award from the ACR in 2007. He attended Yale College, Yale School of Medicine, and Harvard School of Public Health. His residency and fellowship training in rheumatology were completed at Brigham and Women’s Hospital. As well, his clinical practice is at Brigham and Women’s Hospital.
Link to Harvard Catalyst |
Mehdi Najafzadeh, Ph.D., M.Sc., M.A.
Mehdi Najafzadeh PhD, MSc, MA, is an Instructor in Medicine at Harvard Medical School and an associate statistician/epidemiologist in the Division of Pharmacoepidemiology and Phamacoeconomics at the Brigham and Women’s Hospital. He is interested in methods for bridging the gap between randomized and non-randomized data sources used in medical research and currently leads a project for linking randomized clinical trials and claims data for improving methods for evidence generation. His research also involves developing methods for quantitative benefit risk analysis, cost-effectiveness analysis, and economic evaluation. He has experience in modeling and simulation (discrete event simulation, systems dynamic, Markov models), preference elicitation techniques (discrete choice and best-worst scaling experiments), health-related quality of life measures, and statistical analysis and programming.
Link to Harvard Catalyst |
Jessica Franklin, Ph.D.
Jessica Franklin, PhD, is an Assistant Professor of Medicine at Harvard Medical School and biostatistician in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Her research focuses on developing and applying statistical methods for the study of medicines, including comparative effectiveness and adverse effects of drugs, the consequences of drug policy, and drug utilization. Her methodological interests are in causal inference and hierarchical modeling. Dr. Franklin received her Bachelor’s degree in mathematics at the University of Georgia and her doctorate in biostatistics at the Johns Hopkins Bloomberg School of Public Health
Link to Harvard Catalyst |
Students, Fellows and Trainees
Sarah Chen, M.D.
Rheumatology Fellow
Research Staff
Collaborators
Candace Feldman, M.D., Sc.D. |
Tracy Jennifer Doyle, M.D., M.P.H |
Physician at Brigham And Women's Hospital
|
Associate Physician, Brigham and Women's Hospital, Assistant Professor, Harvard Medical School
|
Katherine P Liao, M.D., M.P.H. |
Julie M Paik M.D., Sc.D. |
Associate Physician, Brigham and Women's Hospital, Assistant Professor, Harvard Medical School
|
Associate Physician at Brigham and Women's Hospital, Assistant Professor at Harvard Medical School
|
Kazuki Yoshida Sc.D, M.P.HAssociate Epidemiologist at Brigham and Women's Hospital
|
Jeffery N Katz, M.D., M.ScProfessor of Medicine and Orthopaedic Surgery at Harvard Medical School
|
Sonia Friedman, M.D.Physician at Brigham And Women's Hospital
|
Lindsay A MacFarlane, M.D., M.P.H.Physician at Brigham And Women's Hospital
|
Miin Roh, M.D., Ph.D.Surgeon at Josilin Diabetes Center
|
Joseph Merola, M.D., M.M.Sc.Associate Professor of Dermatology at Harvard Medical School and Physician at Brigham and Women's Hospital
|
Jeffery A Sparks, M.D., M.M.Sc. |
Elaine W. Yu, M.D., M.Sc |
Associate Physician at Brigham and Women's Hospital, Assistant Professor of Medicine at Harvard Medical School
|
Assistant Professor in Medicine at Harvard Medical School, Director at MGH Bone Density Center
|
PRIME is a program of Division of Phamacoepidemiology & Pharmacoeconomics
|
Proudly powered by Weebly